Updated on 21 November 2023
File name
Estr_Crm_IE_S_1mg-g_v6.pdf
Reasons for updating
- Change to section 4.4 - Special warnings and precautions for use
- Change to section 4.6 - Pregnancy and lactation
- Change to Section 4.8 – Undesirable effects - how to report a side effect
- Change to section 10 - Date of revision of the text
Legal category:Product subject to medical prescription which may be renewed (B)
Updated on 21 November 2023
File name
Estr_Crm_IE_S_1mg-g_v6.pdf
Reasons for updating
- Change to section 4.4 - Special warnings and precautions for use
- Change to section 4.6 - Pregnancy and lactation
- Change to Section 4.8 – Undesirable effects - how to report a side effect
- Change to section 10 - Date of revision of the text
Legal category:Product subject to medical prescription which may be renewed (B)
Updated on 21 November 2023
File name
Estr_Crm_IE_P_1mg-g_v8.pdf
Reasons for updating
- Change to section 2 - what you need to know - warnings and precautions
- Change to section 4 - how to report a side effect
- Change to section 5 - how to store or dispose
- Change to section 6 - date of revision
Updated on 31 January 2023
File name
Estr_Crm_IE_S_1mg-g_v5.pdf
Reasons for updating
- Document format updated
Legal category:Product subject to medical prescription which may be renewed (B)
Updated on 05 November 2020
File name
Estr_Crm_IE_S_1mg-g_v5.pdf
Reasons for updating
- Change to section 4.4 - Special warnings and precautions for use
- Change to section 4.8 - Undesirable effects
- Change to section 10 - Date of revision of the text
Legal category:Product subject to medical prescription which may be renewed (B)
Updated on 05 November 2020
File name
Estr_Crm_IE_P_1mg-g_Apr2018_v5.pdf
Reasons for updating
- Change to section 2 - what you need to know - warnings and precautions
- Change to section 4 - possible side effects
Updated on 23 December 2019
File name
Estr_Crm_IE_S_1mg-g_v4.pdf
Reasons for updating
- Change to section 4.1 - Therapeutic indications
- Change to section 4.2 - Posology and method of administration
- Change to section 4.3 - Contraindications
- Change to section 4.4 - Special warnings and precautions for use
- Change to section 4.5 - Interaction with other medicinal products and other forms of interaction
- Change to section 4.8 - Undesirable effects
- Change to section 5.1 - Pharmacodynamic properties
- Change to section 5.2 - Pharmacokinetic properties
- Change to section 10 - Date of revision of the text
Legal category:Product subject to medical prescription which may be renewed (B)
Updated on 23 December 2019
File name
Estr_Crm_IE_P_1mg-g_Apr2018_v5.pdf
Reasons for updating
- Change to Section 1 - what the product is
- Change to section 2 - what you need to know - warnings and precautions
- Change to section 2 - interactions with other medicines, food or drink
- Change to section 3 - how to take/use
- Change to section 4 - possible side effects
- Change to section 6 - date of revision
Updated on 08 October 2019
File name
Estr_Crm_IE_S_1mg-g_Feb2017_v3.pdf
Reasons for updating
- New SPC for new product
Legal category:Product subject to medical prescription which may be renewed (B)
File name
Estr_Crm_IE_P_1mg-g_Apr2018_v5.pdf
Updated on 18 May 2018
File name
Estr_Crm_IE_P_1mg-g_Apr2018_v5.pdf
Reasons for updating
- Change to section 6 - manufacturer
- Change to date of revision
Updated on 14 February 2017
File name
PIL_15975_46.pdf
Reasons for updating
- New PIL for new product
Updated on 14 February 2017
Reasons for updating
- Change to section 2 - what you need to know - warnings and precautions
- Change to section 6 - marketing authorisation holder
- Change to section 6 - date of revision
Updated on 14 March 2016
Reasons for updating
- Change to date of revision
- Addition of information on reporting a side effect.
- Correction of spelling/typing errors
Updated on 31 March 2015
Reasons for updating
- Change to date of revision
- Change to name of manufacturer
Updated on 11 April 2014
Reasons for updating
- New PIL for medicines.ie